Monitor closing conditions — particularly the Envoy Convertible Noteholder's joinder and Israeli/TASE approvals. Post-closing, watch for the proxy statement filing and stockholder vote on Series C conversion, which is the key catalyst for full dilution. BladeRanger's lock-up expires April 2027, creating a potential overhang.
Price Chart
Executive Summary
CID HoldCo (DAIC) entered into a Securities Purchase Agreement to acquire 100% of Envoy Technologies from BladeRanger Ltd. for $65M in stock (10.8M shares at $6.00 reference price). The acquisition is structured as a stock-for-stock deal with Series C Convertible Preferred and common shares, subject to stockholder approval for full conversion. BladeRanger gets board and management designations, lock-up provisions, and anti-dilution protections.
Key Facts
- CID HoldCo will acquire 100% of Envoy Technologies for $65M in stock (10,833,333 Envoy-Side Shares at $6.00 reference price)
- Consideration includes 233,543 common shares and 8,433,123 Series C Preferred to BladeRanger, plus 2,166,667 Series C Preferred to the Envoy Convertible Noteholder subject to joinder
- Closing targeted for October 6, 2026, subject to conditions including Israeli/TASE approvals and conversion of a $12.5M Envoy Convertible Note
- BladeRanger gets one board seat and one management designee as long as it holds 10%+ of outstanding common stock on as-converted basis
- BladeRanger's conversion shares locked up until earlier of April 1, 2027 or 6 months post-conversion, with 10% daily volume leak-out thereafter
- Stockholder approval required under Nasdaq Rules 5635(a), (b), (d) for full conversion of Series C Preferred; target date January 31, 2027
- Interim anti-dilution protection prevents DAIC from issuing more than 300K shares without BladeRanger consent until full conversion
Financial Impact
$65M acquisition consideration in stock; $12.5M Envoy Convertible Note converting pre-closing; $700K lease backstop assumed by buyer
Risk Factors
- Envoy Convertible Noteholder may not execute joinder, potentially blocking closing
- Stockholder approval for Series C conversion may be delayed or denied, keeping the 19.99% blocker in place
- Significant dilution: 10.8M new shares vs 2.3M currently outstanding (pre-LHT settlement)
- 15.7M warrants at $287.50 exercise price create additional overhang
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001213900-26-104299 |
| Document: ea0306797-8k_cidhold.htm | 0001213900-26-104299 |
| Document: 0001213900-26-104299-index-headers.html | 0001213900-26-104299 |
| Document: 0001213900-26-104299-index.html | 0001213900-26-104299 |
| Document: 0001213900-26-104299.txt | 0001213900-26-104299 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | Press Release | $1.20 | awaiting T+5 | — | $1.09 (−9.17%) |
Oct 16, 2026 10d ago | 8-K | $1.05 $1.04 | ▲ +0.95% | ▲ +0.81% | $1.09 (−3.81%) |
Oct 13, 2026 13d ago | DEFA14A | $1.48 $1.24 | ▼ −16.22% | ▼ −16.67% | $1.09 (−26.35%) |
Oct 13, 2026 13d ago | 8-K | $1.48 $1.24 | ▼ −16.22% | ▼ −16.67% | $1.09 (−26.35%) |
Sep 29, 2026 28d ago | DEFA14A | $2.82 $2.51 | ▼ −10.99% | ▼ −12.94% | $1.09 (−61.35%) |
Sep 29, 2026 28d ago | 8-K | $2.82 $2.51 | ▼ −10.99% | ▼ −12.94% | $1.09 (−61.35%) |
Sep 16, 2026 5w ago | DEFA14A | $5.30 $3.41 | ▼ −35.66% | ▼ −36.26% | $1.09 (−79.43%) |
Sep 16, 2026 5w ago | 8-K | $5.30 $3.41 | ▲ +35.66% | ▲ +36.26% | $1.09 (+79.43%) |
Aug 18, 2026 9w ago | 8-K | $0.4200 $5.15 | ▼ −1126.19% | ▼ −1126.58% | $1.09 (−159.52%) |
Aug 12, 2026 10w ago | 8-K | $0.5562 $0.4200 | ▲ +24.49% | ▲ +24.04% | $1.09 (−95.97%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers